Exercise of Options

RNS Number : 7314P

Plant Health Care PLC

20 October 2021

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

Plant Health Care plc

("Plant Health Care" or "the Company")

Exercise of Options,Issue of Equity, Director / PDMR Shareholding

and Total Voting Rights

 
Plant Health Care, a leading provider of novel patent-protected biological products to global agriculturalmarkets,  announce s that on 20 October 202 1   Christopher Richards, Chief Executive Officer, exercised options (the ' Options ')   awarded under the Company's 2017 Employee Share Option Plan (the ' Plan ').  

As announced on 7 October 2020,the Company had awarded 3,250,000 Options to Christopher Richards with an exercise price of 1p per ordinary share in the Company (the ' Ordinary Shares ') under the Plan that vest upon the earlier of: (a) the date of a Change of Control; or (b) upon satisfaction of the Performance-Based Requirement. The Performance-Based Requirement i n respect of 70% of the O ptions (rounded to the nearest whole number) is that no O ption may be exercised until the date on which the arithmetic mean closing price of the Ordinary S hares over 30 consecutive trading dates after the date of grant has exceeded 15p per S hare . This criteria was achieved earlier this year and Dr Richards has now decided to exercise 2,275,000Options.

Of the 2,275,000 Ordinary Shares to be issued(the ' New Ordinary Shares ') following the exercise of the Options, Christopher Richards has sold879,042Ordinary Shares at an aggregate price of £100,146.06, being enough Ordinary Shares to cover the exercise price and associated tax liabilities in respect of the Ordinary Shares issued. Following these transactions, Dr Richards is interested in 4,370,973 Ordinary Shares representing 1.43% of the issued share capital of the Company.

Application for admission of the New   Ordinary Shares to trading on AIM ('Admission') has been made and dealings in the New Ordinary Shares are expected to commence at 8.00 a.m. on 26 October 2021. The New Ordinary Shares will rank pari-passu with the Company's existing issued Ordinary Shares.

Total voting rights

Following Admission, the Company will have 304,662,482 Ordinary Shares in issue with no shares held in treasury. This is the total number of voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Enquiries

Plant Health Care plc	[phone]
Richard Webb - Chairman
Arden Partners plc - Nomad and Joint Broker John Llewellyn-Lloyd / Antonio Bossi	[phone]
Cenkos Securities plc - Joint Broker Neil McDonald / Peter Lynch	[phone]

Company website: www.planthealthcare.com  

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Dr Christopher Richards
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification/Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Plant Health Care plc
b)	LEI	213800KBQPJZ2FM8QH27
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Options over Ordinary Shares of 1p each GB00B 01JC540
b)	Nature of the transaction	Sale of Shares following exercise of options
c)	Price(s) and volume(s)	Price(s) Volume(s) 11.45p 879,042
d)	Aggregated information - Aggregated volume - Price	879,042 £100,146.06
e)	Date of the transaction	20.10. 202 1
f)	Place of the transaction	AIM, London Stock Exchange

 

END

 

 

IOEBRBDGDGDDGBG